Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019;26(1):56-65.
doi: 10.5603/CJ.a2018.0098. Epub 2018 Sep 20.

Sutureless aortic valve replacement in high risk patients neutralizes expected worse hospital outcome: A clinical and economic analysis

Affiliations

Sutureless aortic valve replacement in high risk patients neutralizes expected worse hospital outcome: A clinical and economic analysis

Emmanuel Villa et al. Cardiol J. 2019.

Abstract

Background: Aortic valve replacement (AVR) by sutureless prostheses is changing surgeon options, although which patients benefit most, as well as their possible economic impact is still to be defined.

Methods: Perceval-S prosthesis (LivaNova) is reserved, at the documented Institution, for patients at perceived high surgical risk. This retrospective analysis of outcome and resource consumption compared Perceval with other tissue valves. To clarify the comparison, only patients respecting 'instructions-for- use' of Perceval were reviewed.

Inclusion criteria: > 65 years, +/- coronary artery bypass grafting, patent foramen ovale closure or myectomy.

Exclusion criteria: bicuspid, combined valve or aortic sur- gery. Costs were calculated per patient on a daily basis including preoperative tests, operating costs (hourly basis), disposables, drugs, blood components and personnel.

Results: The sutureless group (SU-AVR) had a higher risk profile than the sutured group (ST-AVR). Cardiopulmonary bypass (CPB) and cross-clamp times were significantly shorter in SU-AVR (isolated AVR: cross-clamp 52.9 ± 12.6 vs. 69 ± 15.3 min, p < 0.001; CPB 79.4 ± 20.3 vs. 92.7 ± 18.2 min, p < 0.001). Hospital mortality was 0.9% in SU-AVR and nil in ST-AVR, p = 0.489; intubation 7 (IQR 5-10.7) and 7 h (IQR 5-9), p = 0.785; intensive care unit 1 (IQR 1-1) and 1 day (IQR 1-1), p = 0.258; ward stay 5.5 (IQR 4-7) and 5 days (IQR 4-6), p = 0.002; pacemaker 5.7% (6/106) and 0.9% (1/109), p = 0.063, respectively. Hospital costs (excluding the prosthesis) were $12,825 (IQR 11,733-15,334) for SU-AVR and $12,386 (IQR 11,217-14,230) in ST-AVR, p = 0.055.

Conclusions: Despite higher operative risks in SU-AVR, hospital mortality, morbidity and resource consumption did not differ. Operative times were shorter with the sutureless device and this improve- ment, along with more frequent ministernotomy, may have improved many postoperative aims.

Keywords: aortic valve; perceval; sutureless.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: Dr. Marco Cirillo and Dr. Giovanni Troise are clinical proctors for LivaNova.

Similar articles

Cited by

References

    1. Max Roser 2016– ‘Life Expectancy’. Published online at OurWorldInData.org; https://ourworldindata.org/life-expectancy/(Online Resource)
    1. Badheka AO, Singh V, Patel NJ, et al. Trends of Hospitalizations in the United States from 2000 to 2012 of Patients > 60 Years With Aortic Valve Disease. Am J Cardiol. 2015;116(1):132–141. doi: 10.1016/j.amjcard.2015.03.053. - DOI - PubMed
    1. Canadian Agency for Drugs and Technologies in Health. Perceval S Sutureless Valve for Aortic Valve Replacement: A Review of the Clinical Effectiveness, Safety, and Cost-Effectiveness [Internet] Ottawa (ON): 2015. Jan 29, http://www.ncbi.nlm.nih.gov/books/NBK349716/ - PubMed
    1. Di Eu, Phan K. Sutureless aortic valve replacement. Ann Cardiothorac Surg. 2015;4(2):123–130. - PMC - PubMed
    1. Al-Sarraf N, Thalib L, Hughes A, et al. Cross-clamp time is an independent predictor of mortality and morbidity in low- and high-risk cardiac patients. Int J Surg. 2011;9(1):104–109. doi: 10.1016/j.ijsu.2010.10.007. - DOI - PubMed

MeSH terms